IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancer.

Liao, Kang-Ling; Bai, Xue-Feng; Friedman, Avner

Liao, Kang-Ling; Bai, Xue-Feng; Friedman, Avner.

Afiliação

Liao KL; Department of Mathematics, University of Manitoba, Winnipeg, MB, Canada. Electronic address: Kang-Ling.Liao@umanitoba.ca.
Bai XF; Department of Pathology and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America.
Friedman A; Mathematical Biosciences Institute, The Ohio State University, Columbus, OH, United States of America; Department of Mathematics, The Ohio State University, Columbus, OH, United States of America.

J Theor Biol ; 579: 111704, 2024 02 21.

Article em En | MEDLINE | ID: mdl-38104658

Assuntos

Interleucina-27; Melanoma; Animais; Camundongos; Interleucina-27/uso terapêutico; Melanoma/patologia; Terapia Combinada; Modelos Teóricos; Imunoterapia/métodos

Palavras-chave

Anti-PD-1; Combination therapy; Immune checkpoint inhibitors; Interleukin-27

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-27 / Melanoma Limite: Animals Idioma: En Revista: J Theor Biol Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google